Budesonida Aldo-Unión 0,5 mg/ml suspensión para inhalación por nebulizador, CUROSURF® 120mg/vial + 240mg/vial Endotracheopulmonary Instillation Suspension
BuS2020
Phase 3 small_molecule active
Quick answer
Budesonida Aldo-Unión 0,5 mg/ml suspensión para inhalación por nebulizador, CUROSURF® 120mg/vial + 240mg/vial Endotracheopulmonary Instillation Suspension for Bronchopulmonary dysplasia, Preterm newborns ≤32 weeks of gestational age. is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Bronchopulmonary dysplasia, Preterm newborns ≤32 weeks of gestational age.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active